CA2095539A1 - Diagnostic et traitement de la sclerose en plaques - Google Patents

Diagnostic et traitement de la sclerose en plaques

Info

Publication number
CA2095539A1
CA2095539A1 CA002095539A CA2095539A CA2095539A1 CA 2095539 A1 CA2095539 A1 CA 2095539A1 CA 002095539 A CA002095539 A CA 002095539A CA 2095539 A CA2095539 A CA 2095539A CA 2095539 A1 CA2095539 A1 CA 2095539A1
Authority
CA
Canada
Prior art keywords
msv
antibody
antigen
antigenic fragment
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002095539A
Other languages
English (en)
Inventor
Robert D. Cook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIVERSITY Co Pty Ltd (THE)
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2095539A1 publication Critical patent/CA2095539A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Pulmonology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
CA002095539A 1990-11-14 1991-11-14 Diagnostic et traitement de la sclerose en plaques Abandoned CA2095539A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPK335290 1990-11-14
AUPK3352 1990-11-14

Publications (1)

Publication Number Publication Date
CA2095539A1 true CA2095539A1 (fr) 1992-05-15

Family

ID=3775068

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002095539A Abandoned CA2095539A1 (fr) 1990-11-14 1991-11-14 Diagnostic et traitement de la sclerose en plaques

Country Status (5)

Country Link
EP (1) EP0557388A4 (fr)
JP (1) JP3266612B2 (fr)
AU (1) AU646522B2 (fr)
CA (1) CA2095539A1 (fr)
WO (1) WO1992008785A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK173091D0 (da) * 1991-10-11 1991-10-11 Schleroseforeningen The Danish Biologisk materiale
GB9310657D0 (en) * 1993-05-24 1993-07-07 Univ London Retrovirus
JP2002511277A (ja) * 1998-04-08 2002-04-16 エムエス・リサーチ・アクティーゼルスカブ 多発性硬化症および他の脱髄性疾患の診断
CN100553636C (zh) 2000-08-04 2009-10-28 Dmi生物科学公司 二酮基哌嗪和包含它们的组合物的使用方法
WO2004030522A2 (fr) 2002-10-02 2004-04-15 Dmi Biosciences, Inc. Diagnostic et controle de maladies
EP2517718B1 (fr) 2003-05-15 2016-03-02 Ampio Pharmaceuticals, Inc. Traitement de maladies à mediation des lymphocytes T
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ，インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (fr) 2010-09-07 2013-10-23 Dmi Acquisition Corp Traitement de maladies
EA028343B1 (ru) 2011-10-10 2017-11-30 Ампио Фармасьютикалз, Инк. Лечение дегенеративного заболевания сустава
MY172699A (en) 2011-10-10 2019-12-10 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
EP2771007B1 (fr) 2011-10-28 2018-04-04 Ampio Pharmaceuticals, Inc. Traitement de la rhinite
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
RU2736513C2 (ru) 2014-08-18 2020-11-17 Ампио Фармасьютикалз, Инк. Лечение патологических состояний суставов
EP3310375A4 (fr) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Utilisation de fractions d'albumine de sérum humain de bas poids moléculaire pour traiter les maladies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ218050A (en) * 1985-11-13 1989-05-29 Wistar Inst Test for the presence of htlv-1v
EP0326395A2 (fr) * 1988-01-29 1989-08-02 City Of Hope Méthode de détection et d'identification de certaines séquences virales

Also Published As

Publication number Publication date
JP3266612B2 (ja) 2002-03-18
AU8955591A (en) 1992-06-11
AU646522B2 (en) 1994-02-24
WO1992008785A1 (fr) 1992-05-29
EP0557388A4 (en) 1994-07-06
JPH06502764A (ja) 1994-03-31
EP0557388A1 (fr) 1993-09-01

Similar Documents

Publication Publication Date Title
CA2095539A1 (fr) Diagnostic et traitement de la sclerose en plaques
Tischer et al. A very small porcine virus with circular single-stranded DNA
Austin et al. Evidence of ortho-and paramyxoviruses in fauna from Antarctica
Eash et al. The human polyomaviruses
Bhattacharya et al. Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress
Poruchynsky et al. Rotavirus protein rearrangements in purified membrane-enveloped intermediate particles
JP2004520841A (ja) 細胞培養物からウイルスを抽出する方法
JP6772155B2 (ja) エンテロウイルス７１動物モデル
Johnson et al. Experimental subacute sclerosing panencephalitis: selective disappearance of measles virus matrix protein from the central nervous system
Maldonado et al. Group-specific antigen shared by the members of the reticuloendotheliosis virus complex
Bekker et al. Factors that affect the intracellular localization and trafficking of African horse sickness virus core protein, VP7
ZA200700323B (en) Recombinant rabies virus compositions
Shao et al. Non-muscle myosin heavy chain 9 is a critical factor for infectious pancreatic necrosis virus cellular entry
JP5841045B2 (ja) 医薬品送達用のウイルス様粒子ベクター、その製造方法、使用、及び医薬組成物
Mulondo et al. Production and immunogenicity of a plant-produced beak and feather disease virus vaccine in Japanese quails
Daniel et al. Herpes virus aotus: a latent herpesvirus from owl monkeys (Aotus trivirgatus) isolation and characterization
KR102711723B1 (ko) 약독화된 레오바이러스 기반의 백신 조성물 및 이의 용도
CN116162582B (zh) 一种展示酸触发性理性膜肽的载药菌影及其制备方法和应用
ES2975182T3 (es) Métodos de producción y caracterización de vacunas víricas y composición de vacuna vírica
Fujimoto et al. Immunocytochemical localization of fodrin and ankyrin in bovine chromaffin cells in vitro.
Lange-Mutschler et al. Cell surface binding simian virus 40 large T antigen becomes anchored and stably linked to lipid of the target cells
JP4785531B2 (ja) マーカーワクチンとしてのニューカッスル病ウイルスのエスケープミュータント
ES2563678T3 (es) Ensayo de agentes extraños
CN120721977A (zh) 表层质蛋白作为靶标在筛选杀灭鱼类体外寄生纤毛虫药物中的应用
Aicher et al. Unpicking the Secrets of African Swine Fever Viral Replication Sites. Viruses 2021, 13, 77

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued